Regarding prognostic factors related to survival, authors found that age, nuclear grade, hormonal and HER-2 status, CSF features, brain, lung, or bone metastasis, systemic or intrathecal chemotherapy, and radiotherapy had no impact in survival. Here, ERBB2 is linked to bone metastasis.